Re: Here is the negative case for MNKD - don't bash, it is worth a read
Shorts are great at twisting the data, people's comments and information in general. I never said they were in violation of SEC rules. What I said is that they probably have a different more comprehensive structure to the retirement of the debt which would explain why we haven't heard anything at this point in time. Otherwise they would be in violation of SEC rules, so all we can do is sit and wait.
I think Adam Fraudstain jumped on the fact that nothing was announced 3 days after the end of the current cycle, so they must have settled it by using cash. Unless Fraudstain has some inside information he is speculating just like myself.
Furthermore, I find it interesting that they announced a presentation at Aegis Capital growth conference only a few days before the event. Usually these events are drawn up months in advance and it appears to be a sudden move by MNKD. To be honest I'm not holding my breathe for any real news as SNY has most of the information under their control. The only thing we might hear is that they have another partnership for additional drug(s) under their platform. What is interesting would be an announcement prior to the conference, so they can address it. Since Aegis is an investment firm you would figure a question would come up about the convertible debt and MNKD would need a way to address it.
I've also noticed a lot of call volume in October over the last week, while not any on the put side in the past week. Its very hard to believe they can sit on the debt conversion information and the clamp study results much longer. The silence is deafening and something has to give. Why go speak at an investment conference without being able to address your finances and future growth plans?